Skip to main content
. 2016 Nov 29;31(5):e22096. doi: 10.1002/jcla.22096

Table 1.

Baseline characteristics of the patients with CIN vs without CIN (Cys C criteria)

Characteristic CIN (N=52) Non‐CIN (N=161) P
Age (y) 50.04±13.16 52.73±14.92 .247
Age >70 y, n (%) 3 (5.8) 21 (13.0) .149
Male, n (%) 39 (75.0) 125 (77.6) .694
Smoke habit, n (%) 31 (59.6) 76 (47.2) .120
Weight (kg) 60.48±8.82 60.85±9.76 .808
Hemoglobin concentration (g/L) 119.96±22.97 127.36±21.26 .034
Baseline serum creatinine (μmol/L) 76.30±35.93 71.94±20.41 .408
Chronic kidney disease, n (%) 6 (11.5) 18 (11.2) .943
Diabetes mellitus, n (%) 4 (7.7) 20 (12.4) .348
Hypertension, n (%) 8 (15.4) 37 (23.0) .243
Hypercholesterolemia, n (%) 7 (13.5) 15 (9.3) .393
Hypoalbuminemia, n (%) 22 (42.3) 35 (21.7) .004
Dehydration state, n (%) 6 (11.5) 7 (4.3) .090
Baseline eGFR (mL/min/1.73 m²) 98.63±23.76 99.26±20.31 .853
Baseline eGFR <90 (mL/min/1.73 m²) 14 (26.9) 48 (29.8) .690
Baseline serum CysC level (mg/L) 1.65±0.73 1.74±0.63 .389
Contrast media volume (mL) 69.00±55.15 58.64±46.00 .181
Multiple CM administrations within 2 wk, n (%) 28 (53.8) 92 (57.1) .677
In‐hospital stay length (d) 13.71±7.63 12.94±5.65 .503

CIN, contrast‐induced nephropathy; eGFR, estimated glomerular filtration rate; CysC, cystatin C; CM, contrast media.